Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
97,693,461
-
Total 13F shares
-
6,458,632
-
Share change
-
+2,849,243
-
Total reported value
-
$3,319,783
-
Put/Call ratio
-
0%
-
Price per share
-
$0.51
-
Number of holders
-
38
-
Value change
-
+$1,060,109
-
Number of buys
-
10
-
Number of sells
-
13
Institutional Holders of Rani Therapeutics Holdings, Inc. - Common Stock (RANI) as of Q2 2025
As of 30 Jun 2025,
Rani Therapeutics Holdings, Inc. - Common Stock (RANI) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,458,632 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, UNITED SERVICES AUTOMOBILE ASSOCIATION, TAKEDA PHARMACEUTICAL CO LTD, GEODE CAPITAL MANAGEMENT, LLC, KESTRA PRIVATE WEALTH SERVICES, LLC, CITADEL ADVISORS LLC, BlackRock, Inc., and NORTHERN TRUST CORP.
This page lists
38
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.